NCT03191747 is a clinical trial in Social Norms, sponsored by Northwestern University.

Who is sponsoring NCT03191747?

NCT03191747 is sponsored by Northwestern University.

What condition does NCT03191747 study?

NCT03191747 studies Social Norms.

Is NCT03191747 still recruiting?

NCT03191747 is currently completed. Last updated 12 July 2018.

Last reviewed 2018-07-12 · How we verify

NCT03191747

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Masculine Norms and Skin Care Knowledge, Attitudes, and Behaviors

Completed Last updated 12 July 2018

What this trial tests

trial in Social Norms in 991 participants. Completed in 2 August 2017.

Timeline

9 June 2017

Primary endpoint
2 August 2017

2 August 2017

Quick facts

Lead sponsor	Northwestern University
Status	Completed
Study type	OBSERVATIONAL
Enrollment	991
Start date	9 June 2017
Primary completion	2 August 2017
Estimated completion	2 August 2017
Sites	1 location across United States

Conditions studied

Social Norms — all drugs for Social Norms →

Sponsor

Northwestern University

Who can join

Adults 18 to 125, male only, with Social Norms. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Examining whether men with greater Avoidance to Femininity subscores using the Male Role Norms Inventory - Short Form will demonstrate differences in skin care knowledge, attitudes, and behaviors, compared to men with lower subscores.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Social Norms

Currently open trials in the same condition.

NCT05873413 — Motivations, Attitudes, and Perceptions Study · NA · recruiting

Other Northwestern University trials

Trials by the same sponsor.

NCT06545695 — Epidermal Growth Factor Receptor Inhibition for Keratinopathies · Phase 1, PHASE2 · not yet recruiting
NCT07261657 — N-803 in Patients With Progressive Synovial Sarcoma and Myxoid/Round Cell Liposarcoma Previously Treated With Adoptive C · EARLY_PHASE1 · not yet recruiting
NCT07392775 — ALDH2 Genetic Testing in East Asian Community · NA · not yet recruiting
NCT06886776 — Implementing A Secure Firearm Storage Program in Illinois Health Centers in Partnership With AllianceChicago and the Ill · NA · not yet recruiting
NCT07469176 — Co-Designing and Evaluating Additional Mothers and Babies Program Content for Expectant and New Parents of Children With · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03191747 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Northwestern University
Last refreshed: 12 July 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03191747.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing